Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
IBRX
IBRX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IBRX News
ImmunityBio to Submit IL-15 Therapy Data Soon
1d ago
stocktwits
ImmunityBio Submits Supplemental BLA for Papillary Disease
1d ago
Newsfilter
ImmunityBio Resubmits ANKTIVA Application to FDA Amid Stock Fluctuations
1d ago
Benzinga
ImmunityBio Resubmits Anktiva Application to FDA
1d ago
stocktwits
ImmunityBio Receives FDA Acknowledgment for ANKTIVA sBLA Submission
1d ago
PRnewswire
FDA Fast-Track Approvals for Two Cancer Drugs
4d ago
stocktwits
ImmunityBio's Anktiva Sales Surge Amid Market Dynamics
5d ago
Fool
ImmunityBio and Iovance Stock Dynamics Analysis
5d ago
stocktwits
U.S. Markets Increased on Wednesday; Moderna Led the Gains
5d ago
Barron's
ImmunityBio Prepares Anktiva Launch in Saudi Arabia Amid Tensions
5d ago
stocktwits
S&P 500 Futures Hold Steady in Pre-Market Session; Moderna and SSR Mining Take the Lead
6d ago
Barron's
Wall Street Declines as Oil Prices Surge Amid Middle East Tensions
6d ago
stocktwits
ImmunityBio Faces Severe Bladder Cancer Therapy Shortage
6d ago
stocktwits
ImmunityBio Earnings Preview and Market Reaction
Mar 03 2026
stocktwits
ImmunityBio Set to Announce Q4 Earnings with Mixed Estimates
Mar 02 2026
seekingalpha
Top Performing Healthcare Stocks in March 2026
Mar 02 2026
seekingalpha
Show More News
